YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Amgen to buy Horizon Therapeutics for $26B

Posted online

Amgen entered a deal to purchase drugmaker Horizon Therapeutics.

The acquisition is valued at more than $26 billion.

Amgen, which makes biotech drugs, would get a treatment for thyroid eye disease through the Horizon deal.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences